Sponsor Pipeline

Fujian Akeylink Biotechnology Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
2
Phase 3
Active Trials by Phase
Phase 3
2
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07090759 To Evaluate the Efficacy, Safety and Population Pharmacokinetics of GST-HG141 in Patients… Chronic Hepatitis b Recruiting
NCT07588009 Phase IIIB Extension Clinical Trial of Efficacy and Safety of GST-HG141 (Nairevir)… Chronic Hepatitis b Not Yet Recruiting
Phase 2
NCT06263959 A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the… Chronic Hepatitis B Recruiting
NCT07709520 Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B Chronic Hepatitis B Recruiting
Get alerts when Fujian Akeylink Biotechnology Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free